Dirk Seegert
10Patents
5h-index
6Co-inventors
55Inventor score
Filing activity: Jun 23, 2004 → Apr 17, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9573989B2 | Sgp130/Fc dimers | Chemistry; Metallurgy | 18 | Active |
| US7534862B2 | PEGylated soluble gp130-dimers useful as a medicament | Chemistry; Metallurgy | 9 | Expired |
| US7629147B2 | PEGylated soluble GP130-dimers useful as a medicament | Chemistry; Metallurgy | 8 | Active |
| US7851182B2 | Soluble GP130 molecule variants useful as a medicament | Human Necessities | 6 | Active |
| US9034817B2 | sgp130/Fc dimers for treatment of inflammatory disease | Chemistry; Metallurgy | 5 | Active |
| US8895012B2 | sgp130/Fc dimers | Chemistry; Metallurgy | 4 | Active |
| US10426765B2 | Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | Human Necessities | 0 | Active |
| US10888555B2 | Pharmaceutical composition containing nicotinic acid and/or nicotinamide for beneficially influencing blood lipid levels by modifying the intestinal microbiota | Human Necessities | 0 | Active |
| US8206948B2 | Optimized nucleotide sequences encoding sgp130 | Chemistry; Metallurgy | 0 | Active |
| US10758552B2 | Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.